 |
|
 |
Allergy / Colds |
|
|
Worldwide Influenza Market; The
Publication Date May 2006
Publisher Business Communications Company
Product Type Report
Pages 122
ISBN Number not applicable
Product Code BCC036
|
|
|
Summary
Annually, more than 3.5 million people die of influenza, and with the threat of a pandemic government agencies and disease prevention organizations are devoted to gain control of the situation. Many companies have been asked to assist with the problem and others are furthering their position with backing from government agencies. The next year will continue to display support and funding for many research and development programs, product development and pandemic prevention and/or control.
This new report from BCC Research is designed to be a helpful business tool that will provide thorough evaluation of the market for influenza vaccines, therapeutics, and diagnostics. The geographic scope of this study is worldwide, with emphasis on U.S. data. The report identifies markets in general segments: Vaccines/ Therapeutics and Diagnostics. Each market segment discussion provides detailed information based on product categories, use of products, forecasts, and competitive analysis. Additionally, the study covers some of most significant issues and trends and market factors.
Scope Of Study
This report:
- Provides a thorough evaluation of the market for influenza vaccines, therapeutics, and diagnostics.
- Offers a global analysis, with emphasis on U.S. data, and a five-year forecast period through 2010.
- Identifies markets in general segments: Vaccines/Therapeutics and Diagnostics. Each market segment discussion provides detailed information based on product categories, use of products, forecasts, and competitive analysis.
- Covers some of the most significant issues, trends and market factors.
- Profiles the top companies and major players in the market.
Report Highlights
- By 2010, the worldwide influenza market is likely to reach $7.1 billion, with average annual growth estimated at 19.8%.
- The worldwide influenza market is estimated at $2.9 billion in 2005, up from $1.5 billion the previous year.
- The market is estimated to reach $7.1 billion in 2010, an increase of more than $4.2 billion over the forecast period.
- The worldwide therapeutics/vaccines market is likely to reach $6.9 billion in 2010, with average annual growth estimated at 20.8%.
|
Content
- Introduction
- Study Goals And Objectives
- Reasons For Doing The Study
- Scope And Format
- Methodology
- Related BCC Studies
- Analyst Credentials
- BCC Online Services
- Disclaimer
- Summary
- The Influenza Market: Major Markets
- Summary Table: Global Forecast Of The Influenza Market By Product Segment, Through 2010 ($ Million)
- Summary Figure: Worldwide Influenza Market Analysis By Product Segment, 2003-2010 ($ Millions)
- Industry Overview
- Industry Overview
- History Of The Market
- Epidemics/Pandemics
- Spanish Influenza 1918-1919
- Hong Kong Influenza 1968
- Russian Influenza 1977
- Asian Influenza 1957
- Swine Flu 1976
- Avian Flu 1961, 1997, 2003-Present
- Virus Mutations
- Types Of Influenza
- Influenza Type A
- Influenza A H5
- Influenza A H7
- Influenza A H9
- Influenza Type B
- Influenza Type C
- Viral Surveillance
- Current H5n1 Virus "drift And Shift"
- Development Of Flu Vaccines
- World Demographics And Incidence/Mortality
- Issues Affecting The Market
- Government Intervention
- United States
- Chinese And United States Governments
- Turkey And The United States
- Who And Cdc
- Who
- The Who And Containment Issues
- Cdc
- Legislation
- Department Of Defense, Emergency Supplemental Appropriations To Address Hurricanes In The Gulf Of Mexico, And Pandemic Influenza Act, 2006
- Global Network For Avian Influenza Surveillance Act
- Pandemic Preparedness And Response Act
- Pandemic And Seasonal Influenza Act Of 2005
- Seasonal Influenza And Pandemic Preparation Act Of 2005
- National Biodefense And Pandemic Preparedness Act Of 2005
- Epidemic/Pandemic Preparedness
- Immaterialized Market Risk
- Vaccine Stockpiles
- Media Coverage And Vaccinations
- Epidemic/Pandemic Threat
- Technology
- Current Uses Of Technology
- Cdc Testing Kit
- Bd Medical And Glaxosmithkline
- Patent Analysis
- Emerging Areas Of Technology
- Stmicroelectronics And Veredus Laboratories
- Sanofi Pasteur And Bd Biosciences
- Nasal Powder Vaccine
- Influenza Therapies/Vaccines
- Overview
- Product Descriptions
- Research And Development
- Market Analysis
- Leading Suppliers And Participants
- Influenza Diagnostics
- Overview
- Product Descriptions
- Conventional Laboratory Tests
- Rapid Testing
- Laboratory Test Services
- Market Analysis
- Leading Suppliers And Participants
- Market Summary
- Total Market Analysis
- Industry Participants
- Company Profiles
- Acambis
- Alphavax, Inc.
- Alnylam Pharmaceuticals
- Applied Biosystems
- Avi Biopharma
- Becton-Dickinson
- Biocryst Pharmaceuticals, Inc.
- Biota Holdings Ltd.
- Chiron Corp.
- Endo Pharmaceuticals Holdings Inc.
- Forest Laboratories, Inc.
- Glaxosmithkline Plc
- Hemispherx Biopharma, Inc.
- Inverness Medical-Biostar, Inc.
- Medimmune Vaccines, Inc.
- Otsuka Pharmaceutical Co., Ltd.
- Pathology Associates Medical Laboratories (PAML)
- Quest Diagnostics
- Quidel Corp.
- Remel, Inc.
- Roche Holdings Ltd.
- Sanofi Pasteur
- Solvay Pharmaceuticals, Inc.
- Sysmex Corp.
- Teva Pharmaceuticals Industries Ltd.
- Viromed Laboratories, Inc.
- Zymetx, Inc.
- Appendix
- Leading Product Providers
- Research And Development And Affiliated Companies
- Mentioned Universities
- Relevant Associations And Organizations
- List Of Figures
- Summary Table: Global Forecast Of The Influenza Market By Product Segment, Through 2010 ($ Million)
- Table 1 Vaccine Recommendations
- Table 2 Worldwide Influenza Activity
- Table 3 Viral Surveillance, Percentage Of Influenza Virus Type, 2004-2005 And 2005-2006 Flu Seasons (%)
- Table 4 Influenza Research Teams And Areas Of Study
- Table 5 Estimated Global Population By Selected Age Group, 2003-2010 (MILLIONS)
- Table 6 Estimated World Population Including Some Countries, 2003-2010 (MILLIONS)
- Table 7 Worldwide Viral Statistics, 2005
- Table 8 United States Viral Statistics, 2005
- Table 9 Countries With U.S. Embargoes For Birds
- Table 10 Who Reported Cases Of Avian Flu In Humans, March 2006
- Table 11 Approved Who Influenza Centers By Region
- Table 12 Confirmed Cases Of Avian Flu Outbreaks In Animals Worldwide, 2003 To Present
- Table 13 Allocated Funds For Influenza Research And Development
- Table 14 Estimated Incidence Of Influenza In Severe Outbreaks Based On Population Estimates, U.S. Census Bureau International Database
- Table 15 Predicted Impact On Health Services From The Next Influenza Pandemic In The Tropics, Based On Cdc's Fluaid Prediction Model For Peak Week
- Table16 U.S. Patent Evaluation For Major Technology By Issue Date
- Table 17 U.S. Patent Evaluation For Major Influenza Market Competitors, By Patent Holder And Number Of Patents
- Table 18 Marketed Flu Virus Products, Through 2005
- Table 19 Generic Availability
- Table 20 Vaccine Average Price Per Unit Dose, 2005-2006 Influenza Season
- Table 21 Research And Development Efforts By Status
- Table 22 Global Forecast For Influenza Therapeutic And Vaccine Revenues By Market, Through 2010 ($ Millions)
- Table 23 Global Forecast For Influenza Therapeutics And Vaccines By Product Type, Through 2010 ($ Millions)
- Table 24 Units For Influenza Therapeutics And Vaccines By Product, 2005-2006 Season (Million Units)
- Table 25 Leading Participants For Influenza Therapeutics/Vaccines By Percent, 2005 (%)
- Table 26 Influenza Diagnostic Table
- Table 27 Marketed Products, Through 2005
- Table 28 Rapid Influenza Tests Average Price
- Table 29 Providers Of Laboratory Test Services
- Table 30 Revenues For Influenza Diagnostics By Market, Through 2010 ($ Millions)
- Table 31 Revenues For Influenza Diagnostics By Product Type, Through 2010 ($ Millions)
- Table 32 Global Forecast Of Influenza Diagnostics Service Revenues, Through 2010 ($ Millions)
- Table 33 Global Forecast Of Influenza Diagnostic Product And Services Market Revenues, Through 2010 ($ Million)
- Table 34 Leading Participants For Influenza Diagnostics By Percent, 2005 (%)
- Table 35 Global Forecast Of The Influenza Market By Product Segment, Through 2010 ($ Million)
- Table 36 Major Industry Participants By Product Segment
- List Of Figures
- Summary Figure: Worldwide Influenza Market Analysis By Product Segment, 2003-2010 ($ Millions)
- Figure 1 Estimated World Population By Selected Age Group, 2003-2010 (MILLIONS)
- Figure 2 Estimated World Population By Region, 2003-2010 (MILLIONS)
- Figure 3 U.S. Patent Evaluation For Major Influenza Technology Patent Holders, By Percent (%)
- Figure 4 Global Forecast For Influenza Therapeutics And Vaccines By Region, 2003-2010 ($ Millions)
- Figure 5 Revenues For Influenza Therapeutics And Vaccines By Product Type, 2003-2010 ($ Millions)
- Figure 6 Share Of Units For Influenza Therapeutics And Vaccines By Product, 2005-2006 Season (%)
- Figure 7 Leading Participants For Influenza Therapeutics/Vaccines By Percent, 2005 (%)
- Figure 8 Revenues For Influenza Diagnostics By Market, 2003-2010 ($ Millions)
- Figure 9 Revenues For Influenza Diagnostics By Product Type, 2003-2010 ($ Millions)
- Figure 10 Revenues For Influenza Diagnostics Services, 2003-2010 ($ Millions)
- Figure 11 Global Influenza Diagnostic Product And Services Market Revenues, 2003-2010 ($ Million)
- Figure 12 Leading Participants For Influenza Diagnostics By Percent, 2005
- Figure 13 Global Forecast Of The Influenza Market By Product Segment, 2003-2010 ($ Million)
- Figure 14 Companies Mentioned In The Market For Influenza Treatments And Diagnostics, By Type (Number Of Companies)
|
|
|
